3004.90.92.84 - Containing albuterol sulfate 🖩

This HTS classification covers medicaments containing albuterol sulfate, intended for therapeutic or prophylactic uses and presented in measured doses or retail packaging. Albuterol sulfate is a bronchodilator commonly used to treat or prevent breathing problems in people who have asthma or chronic obstructive pulmonary disease (COPD). The classification specifically applies to these preparations when they are not included in other more specific categories like those for antihistamines.

Distinguishing this category from its sibling, 3004.90.92.80 (Antihistamines), is crucial. While both fall under medicaments affecting the respiratory system, this category is for albuterol sulfate-containing products, whereas the sibling category is reserved for antihistamine medications. This distinction is based on the active pharmaceutical ingredient and its primary therapeutic effect.

As a leaf node in the HTS structure, this classification does not have further subdivisions. Therefore, classification within 3004.90.92.84 hinges on the presence of albuterol sulfate as a key active ingredient in a pharmaceutical preparation intended for respiratory treatment. Examples include metered-dose inhalers, nebulizer solutions, or oral tablets where albuterol sulfate is the primary therapeutic agent for managing airway constriction.